Page last updated: 2024-08-24

nafagrel and f-chemotactic peptide

nafagrel has been researched along with f-chemotactic peptide in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abe, K; Funakoshi, M; Horiguchi, S; Karibe, A; Katoh, H; Keitoku, M; Kohzuki, M; Nose, M; Okayama, H; Satoh, S; Shirato, K; Suzuki, S; Takeuchi, M; Watanabe, J1

Other Studies

1 other study(ies) available for nafagrel and f-chemotactic peptide

ArticleYear
FMLP actions and its binding sites in isolated human coronary arteries.
    Journal of molecular and cellular cardiology, 1997, Volume: 29, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Coronary Vessels; Cyclooxygenase Inhibitors; Cytochrome P-450 Enzyme System; Endothelium, Vascular; Enzyme Inhibitors; Female; Humans; Imidazoles; Indomethacin; Intramolecular Oxidoreductases; Isomerases; Isometric Contraction; Macrophages; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Oligopeptides; Prostaglandins; Receptors, Formyl Peptide; Receptors, Immunologic; Receptors, Peptide; RNA, Messenger; Tetrahydronaphthalenes; Thromboxane A2; Thromboxane-A Synthase

1997